[HTML][HTML] Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
…, J Hollenberg, M Dahlberg, O Stackelberg, J Litorell… - Critical Care, 2020 - Springer
Background A substantial proportion of critically ill COVID-19 patients develop thromboembolic
complications, but it is unclear whether higher doses of thromboprophylaxis are …
complications, but it is unclear whether higher doses of thromboprophylaxis are …
[HTML][HTML] Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19-a post hoc analysis of the randomized, blinded …
S Jonmarker, F Alarcón, J Litorell, A Granholm… - Annals of Intensive …, 2023 - Springer
Background Thromboembolism is more common in patients with critical COVID-19 than in
other critically ill patients, and inflammation has been proposed as a possible mechanism. …
other critically ill patients, and inflammation has been proposed as a possible mechanism. …
An observational study of intermediate‐or high‐dose thromboprophylaxis for critically ill COVID‐19 patients
S Jonmarker, J Litorell, M Dahlberg… - Acta …, 2022 - Wiley Online Library
Background Critically ill COVID‐19 patients have a high reported incidence of thromboembolic
complications and the optimal dose of thromboprophylaxis is not yet determined. The aim …
complications and the optimal dose of thromboprophylaxis is not yet determined. The aim …
[HTML][HTML] A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical …
S Jonmarker, J Litorell, F Alarcon, K Al-Abani… - Thrombosis …, 2023 - Springer
Background Patients with critical COVID-19 have a high risk of thromboembolism, but
intensified thromboprophylaxis has not been proven beneficial. The activity of low-molecular-…
intensified thromboprophylaxis has not been proven beneficial. The activity of low-molecular-…
DOSING OF THROMBOPROPHYLAXIS AND MORTALITY IN CRITICALLY ILL COVID-19 PATIENTS (preprint)
…, J Hollenberg, M Dahlberg, O Stackelberg, J Litorell… - 2020 - pesquisa.bvsalud.org
Background: A substantial proportion of critically ill COVID-19 patients develop thromboembolic
complications, but it is unclear whether higher doses of thromboprophylaxis are …
complications, but it is unclear whether higher doses of thromboprophylaxis are …
[HTML][HTML] Antifactor Xa activity in critically ill patients receiving antithrombotic prophylaxis with standard dosages of certoparin: a prospective, clinical study
S Jochberger, V Mayr, G Luckner, DR Fries, AJ Mayr… - Critical Care, 2005 - Springer
Introduction Deep venous thrombosis with subsequent pulmonary embolism or post-thrombotic
syndrome is a feared complication in the intensive care unit. Therefore, routine …
syndrome is a feared complication in the intensive care unit. Therefore, routine …
The development of a model capable of predicting diesel lean NOx catalyst performance under transient conditions
…, AM Jones, RR Rajaram, AP Walker, M Litorell… - Applied Catalysis B …, 1996 - Elsevier
Steady state kinetics data from a commercial Pt-based lean NO x catalyst have been used
to formulate a kinetic model to describe the performance of the catalyst. It is clear from this …
to formulate a kinetic model to describe the performance of the catalyst. It is clear from this …
[HTML][HTML] Large variation in anti-factor Xa levels with nadroparin as thromboprophylaxis in COVID-19 and non-COVID-19 critically ill patients
MMR de Maat, HJ van Leeuwen, L Roovers… - BMC Pharmacology and …, 2024 - Springer
Purpose Critically ill COVID-19 and non-COVID-19 patients receive thromboprophylaxis with
the LMWH nadroparin. Whether a standard dosage is adequate in attaining the target anti-…
the LMWH nadroparin. Whether a standard dosage is adequate in attaining the target anti-…
[BOOK][B] Treatment of Coagulopathy in Patients with Critical Covid-19
S Jonmarker - 2023 - search.proquest.com
… Together with my dear colleague and co-author, Jacob Litorell, we started to build a
database with all the information about our patients and their treatment, with the aim of …
database with all the information about our patients and their treatment, with the aim of …
Increased biogas production in the municipality of Borås-A STUDY OF ORGANIC MATERIALS THAT CAN BE UTILIZED FOR ANAEROBIC DIGESTION IN THE …
J Axelsson - 2021 - odr.chalmers.se
South of Borås, at Sobacken, biogas is produced from out-sorted food waste. Organic
material is degraded in an anaerobic digestion process which results in biogas. The plant is …
material is degraded in an anaerobic digestion process which results in biogas. The plant is …
